Matches in Wikidata for { <http://www.wikidata.org/entity/Q87009671> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q87009671 description "artículu científicu espublizáu en marzu de 2015" @default.
- Q87009671 description "im März 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87009671 description "scientific article published on 26 March 2015" @default.
- Q87009671 description "wetenschappelijk artikel" @default.
- Q87009671 description "наукова стаття, опублікована в березні 2015" @default.
- Q87009671 name "A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy" @default.
- Q87009671 name "A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy" @default.
- Q87009671 type Item @default.
- Q87009671 label "A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy" @default.
- Q87009671 label "A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy" @default.
- Q87009671 prefLabel "A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy" @default.
- Q87009671 prefLabel "A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy" @default.
- Q87009671 P1433 Q87009671-6876C101-4B4B-4DC9-9B62-2D1D44C44180 @default.
- Q87009671 P1476 Q87009671-3FA85463-417B-49CF-8978-096A2BC18556 @default.
- Q87009671 P2093 Q87009671-CB2BC98F-AB4E-497E-9254-9A908583BCDA @default.
- Q87009671 P2093 Q87009671-E8FB8927-559E-4E3A-A995-CB878CE495C2 @default.
- Q87009671 P304 Q87009671-6E2C062E-483D-48B0-B510-006D85F274D8 @default.
- Q87009671 P31 Q87009671-1313C101-1593-4BBC-A663-2B6FB1AE605D @default.
- Q87009671 P31 Q87009671-a97903af-f175-4293-b70f-87fb5d674cd7 @default.
- Q87009671 P356 Q87009671-FEE095BB-E6C2-4254-9FCD-497271520C8C @default.
- Q87009671 P433 Q87009671-91D99205-C45C-4520-8A6B-0B8196722C58 @default.
- Q87009671 P478 Q87009671-7003B086-8F96-4024-A080-10E35A32944A @default.
- Q87009671 P577 Q87009671-45AE75DC-2E9F-4DFD-BBC1-D672B1EAFF77 @default.
- Q87009671 P698 Q87009671-E6511685-DF47-4390-B3B0-458E33187122 @default.
- Q87009671 P921 Q87009671-E3E39941-3ABF-4DA7-A762-8DC3AF817C27 @default.
- Q87009671 P356 J.UROLONC.2015.01.026 @default.
- Q87009671 P698 25817318 @default.
- Q87009671 P1433 Q2113446 @default.
- Q87009671 P1476 "A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy" @default.
- Q87009671 P2093 "Gabriel P Haas" @default.
- Q87009671 P2093 "Howard I Scher" @default.
- Q87009671 P304 "269" @default.
- Q87009671 P31 Q13442814 @default.
- Q87009671 P31 Q871232 @default.
- Q87009671 P356 "10.1016/J.UROLONC.2015.01.026" @default.
- Q87009671 P433 "6" @default.
- Q87009671 P478 "33" @default.
- Q87009671 P577 "2015-03-26T00:00:00Z" @default.
- Q87009671 P698 "25817318" @default.
- Q87009671 P921 Q864574 @default.